1. Home
  2. ACHV vs TAYD Comparison

ACHV vs TAYD Comparison

Compare ACHV & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • TAYD
  • Stock Information
  • Founded
  • ACHV N/A
  • TAYD 1955
  • Country
  • ACHV Canada
  • TAYD United States
  • Employees
  • ACHV N/A
  • TAYD N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TAYD Industrial Machinery/Components
  • Sector
  • ACHV Health Care
  • TAYD Industrials
  • Exchange
  • ACHV Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • ACHV 126.9M
  • TAYD 104.2M
  • IPO Year
  • ACHV N/A
  • TAYD N/A
  • Fundamental
  • Price
  • ACHV $3.17
  • TAYD $32.43
  • Analyst Decision
  • ACHV Strong Buy
  • TAYD
  • Analyst Count
  • ACHV 5
  • TAYD 0
  • Target Price
  • ACHV $14.80
  • TAYD N/A
  • AVG Volume (30 Days)
  • ACHV 229.0K
  • TAYD 20.0K
  • Earning Date
  • ACHV 03-27-2025
  • TAYD 03-27-2025
  • Dividend Yield
  • ACHV N/A
  • TAYD N/A
  • EPS Growth
  • ACHV N/A
  • TAYD 27.48
  • EPS
  • ACHV N/A
  • TAYD 2.70
  • Revenue
  • ACHV N/A
  • TAYD $44,486,041.00
  • Revenue This Year
  • ACHV N/A
  • TAYD N/A
  • Revenue Next Year
  • ACHV N/A
  • TAYD N/A
  • P/E Ratio
  • ACHV N/A
  • TAYD $12.00
  • Revenue Growth
  • ACHV N/A
  • TAYD 8.83
  • 52 Week Low
  • ACHV $2.84
  • TAYD $31.30
  • 52 Week High
  • ACHV $5.59
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 44.06
  • TAYD 41.80
  • Support Level
  • ACHV $3.18
  • TAYD $31.30
  • Resistance Level
  • ACHV $3.59
  • TAYD $32.50
  • Average True Range (ATR)
  • ACHV 0.21
  • TAYD 0.96
  • MACD
  • ACHV 0.01
  • TAYD 0.23
  • Stochastic Oscillator
  • ACHV 19.48
  • TAYD 48.29

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: